Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

Creative Commons License

Verheugt F. W. A., Ambrosio G., Atar D., Bassand J., Camm A. J., Costabel J. P., ...Daha Fazla

AMERICAN JOURNAL OF MEDICINE, cilt.132, sa.12, ss.1431-1447, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 132 Sayı: 12
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.amjmed.2019.06.008
  • Dergi Adı: AMERICAN JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1431-1447
  • Anahtar Kelimeler: Anticoagulation, Antiplatelet therapy, Bleeding, Mortality, Stroke, ESC GUIDELINES, MYOCARDIAL-INFARCTION, ANTIPLATELET THERAPY, TRIPLE THERAPY, MANAGEMENT, ASPIRIN, RISK, WARFARIN, REGISTRY, STRATIFICATION
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

BACKGROUND: Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atrial fibrillation patients with a history of acute coronary syndrome. This is a 2-year study of atrial fibrillation patients with or without a history of acute coronary syndromes.